Hypolipidemic activity of Mimosa pudica Linn on Butter Induced Hyperlipidemia in Rats
A. Sowmya and T. Ananthi*
Department
of Biochemistry, S.T.E.T Womens College, Mannagudi- 614001. Thiruvarur District, Tamil Nadu,
India.
*Corresponding Author E-mail: elangani576@gmail.com
ABSTRACT:
The hypolipidemic activity of
Mimosa pudica
extract was studied on high fat diet induced models of hyperlipidemia
in rats. Hyperlipidemia in experimental rats evidenced by an enhancement in the levels of
Cholesterols, Triglycerides, LDL and VLDL. Ehanol
extract showed significant hypolipidemic effect by
lowering the serum levels of biochemical parameters such as significant
reduction in the level of serum Cholesterol, TG, LDL, VLDL and increase in HDL
level which was similar to the standard drug Lovastatin.
Preliminary phytochemical analysis revealed the presence of phytoconstituents
such as steroids, flavonoids, glycosides, alkaloids
and phenolic compounds.
KEYWORDS: High fat diet, Lovastatin, Mimosa pudica, Hyperlipidemia
INTRODUCTION:
Mimosa pudica L. is
common plant in moist waste ground belongs to family – Mimosaceae.
It mainly contains tannins, steroids, triterpenes,
alkaloids, glycosides, flavonoids, c-glycoside,
flavones (Adikari, 2003).The extract of Mimosa pudica
is used in the treatment of migraine, insomnia, headache, diarrhea, dysentery,
fistula, piles, and fever (Rajendran, 2010).The decoction
of M. pudica
antagonized chemically induced seizures in mice. It significantly protected the
mice in PTZ-induced seizures. Plant is also used as a blood purifier (Ghani, 1998). In Ayurvedic and Unani
system of medicine, this plant has been used in diseases arising from corrupted
blood and bile, heart disorders, bilious fever, piles, jaundice, leprosy,
ulcers and small pox.
Hyperlipidemia contributes significantly in the manifestation and
development of atherosclerosis and coronary heart diseases (CHD).
Atherosclerosis, are the most common cause of mortality and morbidity
worldwide. Although several factors, such as diet high in saturated fats and
cholesterol, age, family history, hypertension and life style play a
significant role in causing heart failure (Blackwelder,
1977).
The high levels of cholesterol particularly TC, TG and
LDL cholesterol is mainly responsible for the onset of CHDs. A 20% reduction of
blood cholesterol level can decrease about 31% of CHD incidence, and 33% of its
mortality rate. The known lipid lowering drugs, such as fibrates,
statins and bile acid sequestrants
have many side effects in patients (Chattopadhyaya,1996).
Thus, there is a considerable interest on development of lipid lowering drugs
from natural products in the recent years.
As Mimosa pudica plant species have been traditionally claimed
for the treatment of atherosclerosis; hence, in the present study, an attempt
has been made to screen the herbal extract that is ethanol extract of Mimosa pudica
leaves, for the hypolipidemic activity to prove its
claim in folklore practice.
MATERIALS AND METHODS:
Collection of
plant materials:
Mimosa pudica whole
plants materials were collected from the fields of Thiruvarur
in Tamilnadu.
Preparation
of plant extract:
Mimosa pudica whole
plants were dried at 40ºC for 7 days. Powdered using electric grinder’s server
and stored in a container. This fine cured powder was used as herbal drug.
Weighed amount of dried powdered of Mimosa
pudica whole plant were taken and added 50 ml of
99.9% hot ethanol mixture and evaporated
at 55ºC by using hot air oven, the collected were for hypolipidemic
activity studies.
Preliminary
Phytochemical analysis:
The ethanol extract of M.pudica was subjected to
preliminary phytochemical analysis to assess the presence of various phytoconstituents; it revealed the presence of flavonoids, alkaloids and glycosides (Harborne,1984).
Healthy young male albino rats (130-150 gm) were
purchased from animal house of St, Joseph arts and science college, Tirchy. The groups of rats were kept separately individual
stainless steel hoppers. The test animals should be characterized by strain,
source, sex, weight and age. The animals were kept individually for feeding in
conventional laboratory diets with an unlimited supply of drinking water.
Diagnostics
kits:
Diagnostics kits used for the estimation of lipid
profile (Totalcholesterol, triglycerides, HDL, VLDL,
LDL) were obtained
from Eumic laboratory, Trichy.
Hyperlipidemic inducer:
Butter was used as the hyperlipidemic
inducer in animal procured from Trichy.400mg of butter/Kg b.wt
dissolved in 10ml of buffered saline was used for the induction of hypolipidemic rats.
Experimental
Design:
Group I was considered as control which received 0.5%
sodium carboxy methyl cellulose; Group II was
considered as high fat diet group and received the butter diet; Group III was
considered as test group and received the test extract that is ethanol extract of Mimosa pudica at the dose of 100 mg/ Kg
body weight per oral along with the high fat diet and Group IV was considered
as standard group which received the standard drug Lovastatin
(dose of 75 mg/kg body weight per oral)
along with the high fat diet.
Sample
Collection:
At the end of 21st day, blood serum was
withdrawn from the retro orbital plexus after overnight fasting for the study
of biochemical parameters. Serum was estimated for the total cholesterol,
triglycerides, LDL, VLDL and HDL cholesterol.
Statistical
Analysis:
Results were presented as mean ± SD. The significance
of difference among the groups were assessed using one way analysis of variance
(ANOVA) followed by Dunken’s Multiple Reliance test
using SPSS software.P≤0.05 was considered significant.
RESULTS:
The preliminary phytochemical screening revealed the
presence of phytoconstituents such as glycosides,
alkaloids, flavonoids, tannins, saponins
and phenolic compound in the ethanol extract of Mimosa pudica linn. (Table I)
Table 1:
Phytochemical screening of ethanol extract of Mimosa pudica
|
S. No |
Test |
Constituents of Mimosa pudica |
|
1. |
Alkaloids |
+ |
|
2. |
Carbohydrates |
- |
|
3. |
Saponins |
+ |
|
4. |
Tannins |
+ |
|
5. |
Terpenoids |
- |
|
6. |
Flavanoids |
+ |
|
7. |
Phenol |
+ |
+ indicates presence; -
indicates absence
Hypolipidemic activity:
A marked increase in the level of serum cholesterol,
triglycerides, LDL and VLDL were found in the animals which received high fat
diet and HDL levels were decreased. Administrations of ethanol extract at the
dose of 100 mg/kg showed significant reduction in the level of serum
cholesterol, triglyceride, LDL, VLDL and increase in HDL level which was
similar to the standard Lovastatin, and are almost
near the levels of normal control.
A significant percentage reduction of serum
cholesterol, triglyceride, LDL, VLDL and percentage increase in HDL in test
extract was also comparable with the standard drug. A potent hypolipidemic effect of ethanol extract was evident by a
significant reduction in the level of serum cholesterol, LDL, VLDL and
triglycerides in the cholesterol treated animals and also marked increase in
the HDL Cholesterol level (Table.2).
Table 2:
Effect of Mimosa pudica
on biochemical parameters
|
S. No |
Groups |
Total Cholestrol (mg/dl) |
Triglyceride (mg/dl) |
HDL (mg/dl) |
LDL (mg/dl) |
VLDL (mg/dl) |
|
1 |
Group I (control) |
148± 1.58 |
112.0±51.58 |
61.0 ±1.58 |
88± .42 |
22 ±1.47 |
|
2 |
Group II (Butter Induced) |
232.40±40.48 |
361.0± 1.58 |
38.0 ±1.58 |
161±1.69 |
72.15±1.58 |
|
3 |
Group III (plant extract) |
** 192.90±1.58 |
*** 195.0± 1.58 |
*** 42± 1.58 |
** 106±1.78 |
** 33.0±1.58 |
|
4 |
Group IV (standard Lovastatin) |
*** 149.20± 1.92 |
*** 164.52±1.58 |
*** 37.58±1.31 |
*** 123± .58 |
*** 39 ±1.53 |
Values are expressed as mean ± SEM. Levels of
significance- Group II compared with Group I,III and
IV. **p≤0.01 and ***p≤0.001.
DISCUSSION:
Hyperlipidemia continues to be a health major problem in India and
other developing countries, which lead to important risk factors like
atherosclerosis, stroke etc. Hyperlipidemia evokes
the damages in various tissue, which in turn, deregulates the cellular
functions leading to damage to various pathological conditions (Chander et al.,2003).
The present studies were performed to assess the hypolipidemic activity and to prove its claim in folklore
practice against various disorders. Probucol, a hypolipidemic drug is a potent lipophilic
antioxidant and the ability to inhibit atherosclerosis has been attributed to
its antioxidant properties (Balakrishnan et al., 2006). Probucol lowers the level of cholesterol
in the bloodstream by increasing the rate of LDL catabolism. Additionally, probucol may inhibit cholesterol synthesis and delay
cholesterol absorption. Probucol is a powerful
antioxidant, which inhibits the oxidation of cholesterol in LDLs,
this slows the formation of foam cells, which contribute to atherosclerotic
plaques. Similarly, flavonoids present in the plant Mimosa pudica
may be responsible for its hypolipidemic action and
as already reported significant antioxidant activity of chloroform extract
further confirms its significant hypolipidemic
activity .
Cholesterol is synthesized in all animal tissue. It’s
important relates to its role in the stabilization of membrane structures
because of its rigid planar structure.It also as a
precursor for the synthesis of steroid hormones .
Increased amount of cholesterol leads to cardiovascular disease particularly
coronary heart disease (CHD) (Aparna et al., 2003).
The plasma cholesterol was reduced remarkably on
treating the HFD mice with ethanol extract of Mimosa pudica Linn.The lipid lowering effects may
be due to the presence of plant sterol. Plant sterol reduces the absorption of
cholesterol and thus increases the fecal excretion of steroids that results in
decrease of body lipids
Reduction 1% cholesterol produces a 2% to 3% reduction
in coronary heart disease risk (Ornish et al., 1985).
Triglycerides are mainly stored in the adipose tissue
(Ahire,2005). The plasma lipoproteins are major sources of fatty acid to synthesis triacylglycerols. The excess of fat diet increased the TG
level which is one of the causes of hardening of arteries (XU et al., 2005).
HDL is known as the good cholesterol it has reversed
the transport function. It carries cholesterol away from the including the coronary
categories and drops it off at the liver (Ginsberg and Annapurna,2004).
HDL is directly anti- androgenic and it is belived to remove cholesterol from the developing lesions (Sonnerberg et al.,
1993).
LDL is a risk factor and plays a role at several steps
of atherosclerosis (Witzum, 1994; Alexander, 1995). A
decrease in oxidative stress and protection of LDL from oxidation might
therefore be a strategy with great promise for prevention of atherosclerosis
associated cardiovascular disease (Steinbreg and Gotto, 1999). The
intense interest in this area stems in part from the generally low toxicity of
antioxidants and the hope that treatment with antioxidants might be additive
with cholesterol lowering regimes.
VLDL particles are
smaller than the chylomicrons and also are
rich triglycerides though to a lesser extent VLDL particles sizes vary widely ,with a
concomitant variation of the chemical composition ;the larger particles are rich in
triglycerides and in apo-c and the smaller
particles depleted of TG andsurface materials result
from the hydrolysis of VLDL by lipoprotein lipase activity. VLDL is the main
carrier if triglycerides and it is less harmful than but still can damage the
arterial lining .
VLDL production is directly related to the body fat (Kesavalu et al.,
2001).Severe elevation in the VLDL
cholesterol lead to hypercholesterolemia Triglycerides are mainly stored in the
adipose tissue .The plasma lipoproteins
are major sources of fatty acid to synthesis triacylglycerols.
The excess of fat diet increased the TG level which is one of the causes of
hardening of arteries (XU et al.,
2005).
CONCLUSION:
In accordance with these results it may be confirmed
that due to the presence of phytoconstituents such as
flavonoids, alkaloids and glycosides in the ethanol
extract, it could be responsible for the observed significant hypolipidemic activity. In conclusion, it can be said that
the ethanol extract of Mimosa pudica exhibited a significant hypolipidemic activity.
REFERENCES:
1.
Adikari NS. Prevention of disease through cure, Yojana, 36( 1- 3);
2003: 42-44.
2.
Ahire AE and Laddha KS. Hypolipidemic effects of Carthamus tinctorius in rats. Indian Drugs. 42(8): 2005: 545-546.
3.
Alexander RW. Hypertension and pathogenesis of atherosclerosis-
oxidative stress and mediation of arterial inflammatory response – A new
perspective. Hypertension 25: 1995;155-161.
4.
Aparna Berteri R. Risk of
coronary artery heart disease, Health Screen 1; 2003:28-29.
5.
Balakrishnan N, Suresh D, Pandian
GS, Edwin E
and Sheeja E.
Anti-diarrhoeal potential of Mimosa pudica root extracts. Indian J Nat Prod 22(2): 2006; 21-23.
6.
Blackwelder WD . The cause
of complication of
DM Indian Journal of Experimental Biology 25; 1977: 490.
7.
Chander R, Kapoorn K and
Singh C. Lipid per oxidation of hyperlipidemic rat serum
in chronic ethanol and
acetaldehyde admimistration J
Biosciences 13; 2003:289-274.
8.
Chattopadhyaya R, Pathak D and Jindal DP. Indian
Drugs 33: 1996; 85-97.
9.
Ghani A. Medicinal plants of Bangladesh with chemical
constituents and uses. 1998. Dhaka: Asiatic society of Bangladesh; 2nd
ed.
10. Ginsberg H and Annapurna
N.A Lipoprotein physiology in non
diabetic and diabetic status relation to
atherogenesis. J.
Debetic Care 2004: 839-855.
11. Harborne JB. Phytochemical
methods: a guide to modern technique of plant analysis. 1984: NewYork: Chapman and Hall; 2nd ed.
12. Kesavulu M, Kemeshwara
M, Rao B and Giri R. lipid peroxidation
and antioxodent
enzyme status in type to diabetics with coronary heart disease
, Diab Res and Clin Prac., 1(53); 2001: 33-39.
13. Ornish D and Rosner B . The
effect of intake of dietary fat JAMA . 49; 2005:
263-267.
14. Rajendran R, Hemachander
R, Ezhilarasan T, Keerthana
C, Saroja DL and Saichand
KV. Phytochemical analysis and in-vitro antioxidant activity of Mimosa pudica
Linn leaves. Research J. Pharm and Tech 3(2):
2010;551-555.
15. Sonnerberg and Zolber L. Risk of
coronary artery heart disease, American Dietic
Association chircago.2009.
16. Steinberg D and Gotto AM. Preventing coronary artery disease by lowering
cholesterol levels- Fifty years from bench to bedside. JAMA 282(21): 1999; 43-50.
17. Witzum JL. The oxidation hypothesis
of atherosclerosis. Lancet 344(8925):
1994;793-795.
18. Xu Y, He Z
and King GL. Introduction of
hyperglycemia and dyslipidemia in the pathogenesis of
diabetic vascular complications. Curr Diab Rep 5(2); 2005: 91-97.
Received on 03.10.2011 Accepted
on 21.10.2011
© Asian Pharma Press All
Right Reserved
Asian J. Res. Pharm. Sci. 1(4): Oct.-Dec. 2011; Page 123-126